Canine leishmaniasis: Update on epidemiology, diagnosis, treatment, and prevention

M Morales-Yuste, J Martín-Sánchez… - Veterinary Sciences, 2022 - mdpi.com
Simple Summary Dogs are the main host of Leishmania infantum, a parasite that causes an
incurable disease called canine leishmaniasis. This parasite is transmitted through the bite …

Canine leishmaniasis: an overview of the current status and strategies for control

RR Ribeiro, MSM Michalick, ME da Silva… - BioMed research …, 2018 - Wiley Online Library
Canine leishmaniasis (CanL) is a vector‐borne disease caused by Leishmania infantum
and is transmitted by female phlebotomine sand flies primarily between animals and …

Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection

ND Glennie, VA Yeramilli, DP Beiting… - Journal of Experimental …, 2015 - rupress.org
Leishmaniasis causes a significant disease burden worldwide. Although Leishmania-
infected patients become refractory to reinfection after disease resolution, effective immune …

Canine leishmaniosis in the Old and New Worlds: unveiled similarities and differences

F Dantas-Torres, L Solano-Gallego, G Baneth… - Trends in …, 2012 - cell.com
Canine leishmaniosis is a potentially life-threatening disease which is spreading
geographically in the Old and New Worlds, where different diagnostic procedures …

Current status on prevention and treatment of canine leishmaniasis

RM Reguera, M Moran, Y Perez-Pertejo… - Veterinary …, 2016 - Elsevier
Canine leishmaniasis (CanL) is a parasite-borne disease mainly induced by Leishmania
infantum in the Old World and Leishmania chagasi (infantum) in the New World. CanL is a …

Overcoming roadblocks in the development of vaccines for leishmaniasis

PM Kaye, S Mohan, C Mantel, M Malhame… - Expert Review of …, 2021 - Taylor & Francis
Introduction The leishmaniases represent a group of parasitic diseases caused by infection
with one of several species of Leishmania parasites. Disease presentation varies because …

[HTML][HTML] An overview on Leishmania vaccines: A narrative review article

H Rezvan, M Moafi - Veterinary research forum, 2015 - ncbi.nlm.nih.gov
Leishmaniasis is one of the major health problems and categorized as a class I disease
(emerging and uncontrolled) by World Health Organization (WHO), causing highly …

Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends

A Badiee, VH Shargh, A Khamesipour, MR Jaafari - Vaccine, 2013 - Elsevier
Leishmania infection continues to have a major impact on public health inducing significant
morbidity and mortality mostly in the poorest populations. Drug resistance, toxicity and side …

Synthesis, characterization, and antileishmanial activity of neutral N-heterocyclic carbenes gold (I) complexes

C Zhang, SB Delmas, ÁF Álvarez, A Valentin… - European journal of …, 2018 - Elsevier
A series of five new mononuclear neutral gold (I) complexes containing N-heterocyclic
carbenes (NHCs) was synthesized and fully characterized by spectroscopic methods. The X …

Modular multiantigen T cell epitope–enriched DNA vaccine against human leishmaniasis

S Das, A Freier, T Boussoffara, S Das… - Science translational …, 2014 - science.org
The leishmaniases are protozoal diseases that severely affect large populations in tropical
and subtropical regions. There are only limited treatment options and preventative …